ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,127.79
1.26%
US Tech 100
17,444.00
2.16%
다우존스 지수
38,675.68
1.18%
Bitcoin
62,769.62
6.17%
Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Enanta Pharmaceuticals Inc (ENTA)

  7. Enanta Pharmaceuticals Inc (ENTA) 뉴스

ENTA

Enanta Pharmaceuticals (ENTA)

Enanta Pharmaceuticals Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:ENTA
일자시간출처헤드라인심볼기업
2024/04/3020:10Business WireEnanta Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ENTAEnanta Pharmaceuticals Inc
2024/04/3020:00Business WireEnanta Pharmaceuticals Announces the Appointment of Matthew P. Kowalsky as Chief Legal OfficerNASDAQ:ENTAEnanta Pharmaceuticals Inc
2024/04/2920:00Business WireEnanta Pharmaceuticals to Host Conference Call on May 6 at 4:30 p.m. ET to Discuss its Financial Results for its Fiscal Second Quarter Ended March 31, 2024NASDAQ:ENTAEnanta Pharmaceuticals Inc
2024/04/1720:00Business WireEnanta Pharmaceuticals Announces Data Presentation at ESCMID Global 2024NASDAQ:ENTAEnanta Pharmaceuticals Inc
2024/03/0907:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ENTAEnanta Pharmaceuticals Inc
2024/03/0907:27Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ENTAEnanta Pharmaceuticals Inc
2024/03/0907:23Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ENTAEnanta Pharmaceuticals Inc
2024/03/0907:19Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ENTAEnanta Pharmaceuticals Inc
2024/03/0907:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ENTAEnanta Pharmaceuticals Inc
2024/03/0907:12Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ENTAEnanta Pharmaceuticals Inc
2024/03/0621:00Business WireEnanta Pharmaceuticals to Participate at Leerink Partners Global Biopharma ConferenceNASDAQ:ENTAEnanta Pharmaceuticals Inc
2024/02/2808:31Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ENTAEnanta Pharmaceuticals Inc
2024/02/2803:11Edgar (US Regulatory)Form SCHEDULE 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:ENTAEnanta Pharmaceuticals Inc
2024/02/1510:23Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ENTAEnanta Pharmaceuticals Inc
2024/02/1510:21Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ENTAEnanta Pharmaceuticals Inc
2024/02/1510:18Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ENTAEnanta Pharmaceuticals Inc
2024/02/1510:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ENTAEnanta Pharmaceuticals Inc
2024/02/1510:12Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ENTAEnanta Pharmaceuticals Inc
2024/02/1510:09Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ENTAEnanta Pharmaceuticals Inc
2024/02/1510:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ENTAEnanta Pharmaceuticals Inc
2024/02/1504:26Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:ENTAEnanta Pharmaceuticals Inc
2024/02/0914:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:ENTAEnanta Pharmaceuticals Inc
2024/02/0906:24Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ENTAEnanta Pharmaceuticals Inc
2024/02/0806:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ENTAEnanta Pharmaceuticals Inc
2024/02/0806:01Business WireEnanta Pharmaceuticals Reports Financial Results for its Fiscal First Quarter Ended December 31, 2023 with Webcast and Conference Call Today at 4:30 p.m. ETNASDAQ:ENTAEnanta Pharmaceuticals Inc
2024/02/0621:00Business WireEnanta Pharmaceuticals to Participate at the Oppenheimer 34th Annual Healthcare Life Sciences ConferenceNASDAQ:ENTAEnanta Pharmaceuticals Inc
2024/01/3121:00Business WireEnanta Pharmaceuticals to Host Conference Call on February 7 at 4:30 p.m. ET to Discuss its Financial Results for its Fiscal First Quarter Ended December 31, 2023NASDAQ:ENTAEnanta Pharmaceuticals Inc
2024/01/2706:39Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:ENTAEnanta Pharmaceuticals Inc
2024/01/2706:37Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:ENTAEnanta Pharmaceuticals Inc
2024/01/2706:25Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:ENTAEnanta Pharmaceuticals Inc
 검색 관련기사 보기:NASDAQ:ENTA

최근 히스토리

NYSE
XOM
Exxon Mobil
USI
USTECH100
US Tech 100
NYSE
KO
Coca Cola
CCOM
US30
US 30
NASDAQ
AMZN
Amazon.com
NASDAQ
AAPL
Apple
NYSE
MRK
Merck
COIN
BTCUSD
Bitcoin
USOTC
ADDYY
Adidas (QX)
SPI
SP500
S&P 500
NYSE
AXP
American Express
NYSE
MCD
McDonalds
CCOM
US500
US 500
NYSE
DIS
Walt Disney
CCOM
SILVER
SILVER
COIN
SOLUSD
Solana
Delayed Upgrade Clock
ADVFN Logo

대한변국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유